Skip to main content
Caplight Logo









Gurnet Point Capital

Gurnet Point Capital

Cambridge, Massachusettsgurnetpointcapital.com

Overview

Gurnet Point Capital is a healthcare investment firm based in Cambridge, MA, focused on investing in scientifically de-risked life sciences companies. Founded in 2015, the firm employs an active ownership strategy to drive value creation through its financial capabilities, technical knowledge, and operational improvements. Gurnet Point Capital aims to bring safe and effective treatments to market, positively impacting patient outcomes and generating significant returns for investors. The fund invests across all stages of product development through to commercialisation and does so with an approach that is a hybrid of venture and private equity investing strategies.

Year Founded

2013

AUM

$2B

Portfolio Companies

11

Investments

Gurnet Point Capital investments
CompanyDateStageLead
Boston PharmaceuticalsNov 2015Corporate FundingLead
FairtilityMay 2022Series ALead
Macrolide PharmaceuticalsMar 2015Series A-
Before BrandsSep 2019Corporate FundingCo-investor
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Pharm. D Sophie P. Kornowski

Senior Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Gurnet Point Capital based?

Gurnet Point Capital is headquartered in Cambridge, Massachusetts, United States.

When was Gurnet Point Capital founded?

Gurnet Point Capital was founded in 2013.

How many portfolio companies does Gurnet Point Capital have?

Gurnet Point Capital has 11 portfolio companies in Caplight's dataset.

What are some companies in Gurnet Point Capital's portfolio?

Portfolio companies visible on Caplight include Boston Pharmaceuticals, Fairtility, Macrolide Pharmaceuticals, Before Brands.

What was Gurnet Point Capital's most recent investment shown here?

Gurnet Point Capital's most recent investment in this portfolio sample was in Fairtility in 2022.

What sectors does Gurnet Point Capital focus on?

Gurnet Point Capital focuses on Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Enterprise Software.

What company stages does Gurnet Point Capital focus on?

Gurnet Point Capital typically invests at the MultiStage stage.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2013
AUM$2B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?